Xi Shi

Prof. Dr. Xi Shi

Xuzhou Central Hospital, Xuzhou, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MCMeng-Bing Chen
Meng-Bing Chen
MLMeng-Hua Li
Meng-Hua Li
LWLi-Yuan Wu
Li-Yuan Wu
RWRong Wang
Rong Wang
XLXi Long
Xi Long
SYShiming Yang
Shiming Yang

16 July 2024 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
LZLiting Zheng
Liting Zheng
MLMenghua Li
Menghua Li
YLYalan Li
Yalan Li
LWLiyuan Wu
Liyuan Wu
KNKonduru Naveena
Konduru Naveena
XSXi Shi
Xi Shi

18 April 2024 in World Journal of Traditional Chinese Medicine
Verified
Journal Article
Closed access
MLMeng-Hua Li
Meng-Hua Li
WWWan-Qi Wang
Wan-Qi Wang
LZLi-Ting Zheng
Li-Ting Zheng
MCMeng-Bing Chen
Meng-Bing Chen
YCYang Chu
Yang Chu
XSXi Shi
Xi Shi
Objective: This study aimed to explore andrographolide’s mechanism of action and its protective effect on noise-induced hearing loss (NIHL). Materials and Methods: A mice animal model for NIHL was established through exposure to broadband noise at 120 dB sound pressure level for 4 h. Transcriptomics analysis and pharmacodynamic experiments were carried out. Results: Andrographolide enters the inner ear and effectively prevents hearing damage following noise exposure in the mice model for permanent hearing loss. Moreover, treatment with andrographolide inhibited the excessive activation of inflammatory factors in the cochleae of noise-exposed mice. Conclusion: Andrographolide might be a promising candidate for auditory protective drug investigation.